We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FMFC:NASDAQKandal M Venture Limited Analysis

Data as of 2026-06-17 - not real-time

$0.29

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Kandal M Venture Limited (FMFC) is trading at $0.2896, a sharp drop from the prior close of $0.3402, leaving the price well below its 20‑day (≈$0.38) and 50‑day (≈$0.39) simple moving averages. The RSI of 29.5 signals an oversold condition, yet the MACD histogram remains negative and the MACD line sits beneath its signal, confirming a bearish momentum. Volume has been increasing, suggesting heightened trader interest despite the downtrend, while a 30‑day volatility of over 75% underscores a highly erratic price path. The stock’s beta of 1.10 points to slightly higher sensitivity to market swings, and the historic max drawdown of roughly 98% highlights the potential for severe capital erosion.
Fundamentally, FMFC reports a 17% revenue contraction and negative profit margins, with operating cash flow and free cash flow both in the red. The balance sheet shows modest cash reserves ($1.73M) against a relatively high debt‑to‑equity ratio of 1.62, and equity is eroding as reflected by negative ROE and ROA. Valuation multiples are low – a price‑to‑book of 0.66 and price‑to‑sales of 0.34 – implying the market may be pricing in distress rather than intrinsic value. No dividend is paid, and analysts have not issued coverage, leaving investors without external guidance. Overall, the combination of a bearish technical setup, deteriorating fundamentals, and elevated risk metrics suggests caution.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical indicators (price below SMAs, negative MACD)
  • Accelerating volume amid price decline
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential price stabilization near support at $0.24
  • Low valuation multiples offering a floor
  • Continued earnings losses limiting upside

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Fundamental turnaround required for sustainable growth
  • Exposure to emerging‑market regulatory and currency risks
  • Absence of dividend income and analyst coverage

Key Metrics & Analysis

Financial Health

Revenue Growth-17.00%
Profit Margin-1.75%
ROE-6.21%
ROA-2.31%
Debt/Equity1.61
P/B Ratio0.7
Op. Cash Flow$-1916105
Free Cash Flow$-521049

Technical Analysis

TrendBearish
RSI29.5
Support$0.24
Resistance$0.44
MA 20$0.38
MA 50$0.39
MA 200$2.69
MACDBearish
VolumeIncreasing
Fear & Greed Index90.23

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.10
Volatility75.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.